MARKET

RADX

RADX

Radiopharm Theranostics Ltd
NASDAQ
1.650
+0.078
+4.97%
After Hours: 1.650 0 0.00% 16:10 09/25 EDT
OPEN
1.570
PREV CLOSE
1.572
HIGH
1.680
LOW
1.441
VOLUME
37.57K
TURNOVER
--
52 WEEK HIGH
16.25
52 WEEK LOW
1.441
MARKET CAP
23.86M
P/E (TTM)
-0.4441
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RADX last week (0914-0918)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 09/14 21:06
Radiopharm Selected For Late-Breaking Presentation Of Positive RAD101 Phase 2b Data; Stock Up
NASDAQ · 09/14 15:07
Radiopharm Says Data From Interim Analysis Of Phase 2b Imaging Clinical Trial Of 18F-RAD101 In Participants With Suspected Recurrent Brain Metastases From Solid Tumors Selected For Presentation At SNO26 Annual Meeting
Benzinga · 09/14 12:03
Radiopharm Theranostics to Present Positive RAD101 Phase 2b Brain Metastases Data at SNO 2026
TipRanks · 09/14 10:27
Weekly Report: what happened at RADX last week (0907-0911)?
Weekly Report · 09/14 09:53
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 09/11 12:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/10 12:06
More
About RADX
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Webull offers Radiopharm Theranostics Ltd stock information, including NASDAQ: RADX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RADX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RADX stock methods without spending real money on the virtual paper trading platform.